AU1515197A - Methods and compositions for treating infection using optically pure (S)-lomefloxacin - Google Patents

Methods and compositions for treating infection using optically pure (S)-lomefloxacin

Info

Publication number
AU1515197A
AU1515197A AU15151/97A AU1515197A AU1515197A AU 1515197 A AU1515197 A AU 1515197A AU 15151/97 A AU15151/97 A AU 15151/97A AU 1515197 A AU1515197 A AU 1515197A AU 1515197 A AU1515197 A AU 1515197A
Authority
AU
Australia
Prior art keywords
lomefloxacin
compositions
methods
optically pure
treating infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU15151/97A
Inventor
James W. Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunovion Pharmaceuticals Inc
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of AU1515197A publication Critical patent/AU1515197A/en
Priority to AU35753/99A priority Critical patent/AU3575399A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU15151/97A 1991-11-27 1997-03-07 Methods and compositions for treating infection using optically pure (S)-lomefloxacin Abandoned AU1515197A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU35753/99A AU3575399A (en) 1991-11-27 1999-06-18 Methods and compositions for treating infection using optically pure (S)-lomefloxacin

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79924391A 1991-11-27 1991-11-27
US799243 1991-11-27

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU31474/93A Division AU3147493A (en) 1991-11-27 1992-11-25 Methods and compositions for treating infection using optically pure (s)-lomefloxacin

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU35753/99A Division AU3575399A (en) 1991-11-27 1999-06-18 Methods and compositions for treating infection using optically pure (S)-lomefloxacin

Publications (1)

Publication Number Publication Date
AU1515197A true AU1515197A (en) 1997-05-22

Family

ID=25175406

Family Applications (2)

Application Number Title Priority Date Filing Date
AU31474/93A Abandoned AU3147493A (en) 1991-11-27 1992-11-25 Methods and compositions for treating infection using optically pure (s)-lomefloxacin
AU15151/97A Abandoned AU1515197A (en) 1991-11-27 1997-03-07 Methods and compositions for treating infection using optically pure (S)-lomefloxacin

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU31474/93A Abandoned AU3147493A (en) 1991-11-27 1992-11-25 Methods and compositions for treating infection using optically pure (s)-lomefloxacin

Country Status (5)

Country Link
EP (1) EP0614364A4 (en)
JP (1) JPH07503457A (en)
AU (2) AU3147493A (en)
CA (1) CA2124443A1 (en)
WO (1) WO1993010785A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6075024A (en) * 1991-11-27 2000-06-13 Sepracor Inc. Methods for treating infection using optically pure (S)-lomefloxacin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU553415B2 (en) * 1983-09-19 1986-07-17 Abbott Japan Co., Ltd. 6-fluoro-1-4-dihydro-4-oxo-7-substituted piperazinyl- quinoline-3-carboxylic acids
JPS60190777A (en) * 1984-03-12 1985-09-28 Hokuriku Seiyaku Co Ltd Optical active 6,8-difluoro-1,4-dihydro-4-oxo-7-substituted piperazinylquinoline-3-carboxylic acid derivative
JPS618538A (en) * 1984-06-25 1986-01-16 Shimizu Constr Co Ltd Air conditioning mechanism in factory or the like
JP2676521B2 (en) * 1988-03-22 1997-11-17 北陸製薬株式会社 Method for producing quinolonecarboxylic acid compound type I crystal
JPH02115182A (en) * 1988-10-21 1990-04-27 Yoshitomi Pharmaceut Ind Ltd Optically active pyridone-carboxylic acid compound

Also Published As

Publication number Publication date
JPH07503457A (en) 1995-04-13
EP0614364A4 (en) 1994-10-19
AU3147493A (en) 1993-06-28
EP0614364A1 (en) 1994-09-14
WO1993010785A1 (en) 1993-06-10
CA2124443A1 (en) 1993-06-10

Similar Documents

Publication Publication Date Title
AU2187992A (en) Composition and method for disease treatment
AU3201093A (en) Dental composition and method
AU4861493A (en) Clear leave-on treatment composition and method
AU8611591A (en) Method and system for whitening teeth
AU3803193A (en) Dental implant system and apparatus
AU7270091A (en) Method and composition for coiontophoresis
AU7039896A (en) Methods and compositions for treating emesis, nausa and other disorders using optically pure R(+) ondansetron
AU6904498A (en) Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole
AU4408593A (en) Methods and activator compositions to disinfect lenses
AU678971B2 (en) Compositions and methods for vaccination against coronaviruses
AU644245B2 (en) Hair treatment composition
AU4520893A (en) Sterilization process and composition
AU7951591A (en) Methods for treating inflammation and compounds and compositions suitable for use therein
AU2960892A (en) Immunogen composition
AU8192691A (en) Method of treatment and compositions therefore
AU2649092A (en) Desulphurisation treatment
AU6993798A (en) Methods and compositions using optically pure (+)-zileuton
AU3245593A (en) Methods and compositions for treating sleep disorders, convulsive seizures, and other disorders using optically pure (+) zopiclone
AU2685892A (en) Method of treating blood
EP0700292A4 (en) Methods and compositions for treating gastric disorders using optically pure (+) pantoprazole
AU3553489A (en) Novel compounds and treatment
AU8323291A (en) Fiber treatment apparatus
AU1515197A (en) Methods and compositions for treating infection using optically pure (S)-lomefloxacin
AU7366591A (en) Method and composition for water treatment
AU4980693A (en) Improvements in skin plasters